|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM031767230 |
003 |
DE-627 |
005 |
20250126143745.0 |
007 |
tu |
008 |
231221s1988 xx ||||| 00| ||jpn c |
028 |
5 |
2 |
|a pubmed25n0106.xml
|
035 |
|
|
|a (DE-627)NLM031767230
|
035 |
|
|
|a (NLM)3195413
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a jpn
|
100 |
1 |
|
|a Nakajima, K
|e verfasserin
|4 aut
|
245 |
1 |
2 |
|a A clinical evaluation of CS-807 in patients with urinary tract infections
|
264 |
|
1 |
|c 1988
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
500 |
|
|
|a Date Completed 12.01.1989
|
500 |
|
|
|a Date Revised 13.12.2023
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a CS-807 is a new cephalosporin orally available. The clinical efficacy and safety of this drug were evaluated in 13 patients with urinary tract infection, including 3 with simple cystitis and 10 with complicated infections. According to the response criteria defined by the Japanese UTI committee, the clinical effectiveness in 8 patients with complicated urinary tract infections regarded evaluable was excellent in 2, moderate in 4 and poor in 2, the overall efficacy rate being 75.0%. Only 1 of the 13 patients studied, developed temporary diarrhea as a drug related adverse reaction
|
650 |
|
4 |
|a English Abstract
|
650 |
|
4 |
|a Journal Article
|
650 |
|
7 |
|a Anti-Infective Agents, Urinary
|2 NLM
|
650 |
|
7 |
|a Cephalosporins
|2 NLM
|
650 |
|
7 |
|a Ceftizoxime
|2 NLM
|
650 |
|
7 |
|a C43C467DPE
|2 NLM
|
700 |
1 |
|
|a Oshinoya, Y
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Uchibayashi, T
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ohkawa, M
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Hisazumi, H
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Hinyokika kiyo. Acta urologica Japonica
|d 1962
|g 34(1988), 8 vom: 08. Aug., Seite 1515-8
|w (DE-627)NLM012631779
|x 0018-1994
|7 nnns
|
773 |
1 |
8 |
|g volume:34
|g year:1988
|g number:8
|g day:08
|g month:08
|g pages:1515-8
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_20
|
912 |
|
|
|a GBV_ILN_22
|
912 |
|
|
|a GBV_ILN_40
|
912 |
|
|
|a GBV_ILN_60
|
912 |
|
|
|a GBV_ILN_72
|
912 |
|
|
|a GBV_ILN_120
|
912 |
|
|
|a GBV_ILN_350
|
912 |
|
|
|a GBV_ILN_2001
|
912 |
|
|
|a GBV_ILN_2003
|
912 |
|
|
|a GBV_ILN_2005
|
912 |
|
|
|a GBV_ILN_2006
|
912 |
|
|
|a GBV_ILN_2008
|
912 |
|
|
|a GBV_ILN_2010
|
912 |
|
|
|a GBV_ILN_2012
|
912 |
|
|
|a GBV_ILN_2018
|
951 |
|
|
|a AR
|
952 |
|
|
|d 34
|j 1988
|e 8
|b 08
|c 08
|h 1515-8
|